People · Operator
Named in public records as an officer, director or promoter · active 2011–2019 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Biocept Inc | — | Biotechnology | Series A | $35.7M | $366.4M | 2017 |
| Asuragen Inc | — | Biotechnology | Series A | $12.5M | $271.1M | 2011 |
Lyle E. Arnold at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Lyle E. Arnold on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Todd Johnson | 1 | 27 |
| David F Hale | 1 | 16 |
| Ivor Royston | 1 | 7 |
| Evan S. Melrose | 1 | 5 |
| David Hale | 1 | 4 |
| Christopher D Earl | 1 | 3 |
| Farideh Bischoff | 1 | 2 |
| Timothy Kennedy | 1 | 2 |
| Matthew M Winkler | 1 | 2 |
| Bruce A. Huebner | 1 | 2 |
| Edward Dennis | 1 | 1 |
| Bruce Gerhardt | 1 | 1 |
| Claire Reiss | 1 | 1 |
| Edward A Neff | 1 | 1 |
| Meg McGilley | 1 | 1 |
| Raaj W Trivedi | 1 | 1 |
| Stephen Coutts | 1 | 1 |
| Marsha A Chandler | 1 | 1 |
| Faye Wilson | 1 | 1 |
| Lyle W Arnold | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.